Should we characterize Epstein-Barr virus (EBV) as a causative agent of multiple sclerosis (MS), or a risk factor for MS?” Micah Luftig, PhD: “I think we should characterize EBV as an essential ...

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, ...

Plants mobilize their immune defenses far earlier than scientists have believed for decades—and through a previously overlooked early signaling mechanism—according to a new study published in Nature ...

The immune system's reaction to the common Epstein-Barr virus can ultimately damage the brain and contribute to multiple sclerosis (MS), according to new research from Karolinska Institutet, published ...